Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EMBC NASDAQ:INMD NASDAQ:IRMD NASDAQ:OM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMBCEmbecta$14.92-2.1%$12.09$9.20▼$21.48$867.99M1.12595,952 shs78,699 shsINMDInMode$15.22+1.0%$14.54$13.14▼$19.85$958.58M21.25 million shs92,332 shsIRMDiRadimed$71.63-0.4%$65.43$45.89▼$74.00$911.07M1.0244,099 shs1,457 shsOMOutset Medical$13.72-3.3%$15.94$5.85▼$25.35$244.90M2.14220,846 shs4,453 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMBCEmbecta+3.96%+4.17%+24.02%+50.64%-0.59%INMDInMode-1.37%+4.58%+6.80%+5.53%-2.90%IRMDiRadimed+0.06%+0.36%+2.80%+19.80%+59.76%OMOutset Medical+2.75%+3.28%+10.86%-30.51%+91.73%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMBCEmbecta$14.92-2.1%$12.09$9.20▼$21.48$867.99M1.12595,952 shs78,699 shsINMDInMode$15.22+1.0%$14.54$13.14▼$19.85$958.58M21.25 million shs92,332 shsIRMDiRadimed$71.63-0.4%$65.43$45.89▼$74.00$911.07M1.0244,099 shs1,457 shsOMOutset Medical$13.72-3.3%$15.94$5.85▼$25.35$244.90M2.14220,846 shs4,453 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMBCEmbecta+3.96%+4.17%+24.02%+50.64%-0.59%INMDInMode-1.37%+4.58%+6.80%+5.53%-2.90%IRMDiRadimed+0.06%+0.36%+2.80%+19.80%+59.76%OMOutset Medical+2.75%+3.28%+10.86%-30.51%+91.73%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEMBCEmbecta 2.75Moderate Buy$19.0027.39% UpsideINMDInMode 2.13Hold$18.0418.53% UpsideIRMDiRadimed 3.00Buy$72.000.52% UpsideOMOutset Medical 3.00Buy$24.6779.79% UpsideCurrent Analyst Ratings BreakdownLatest OM, INMD, IRMD, and EMBC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/5/2025EMBCEmbectaBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$25.008/26/2025EMBCEmbectaZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy8/19/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSector Perform$22.008/7/2025OMOutset MedicalRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$21.00 ➝ $22.007/30/2025INMDInModeNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold7/30/2025INMDInModeBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$24.00 ➝ $21.007/16/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$13.00 ➝ $12.007/14/2025OMOutset MedicalBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$37.007/11/2025INMDInModeCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$15.00(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEMBCEmbecta$1.12B0.78$3.40 per share4.39($12.80) per share-1.17INMDInMode$394.82M2.44$1.82 per share8.38$10.12 per share1.50IRMDiRadimed$73.24M12.44$1.58 per share45.41$6.85 per share10.46OMOutset Medical$119.30M2.04N/AN/A$7.49 per share1.83Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEMBCEmbecta$78.30M$1.4310.384.860.817.58%-23.40%14.46%11/25/2025 (Estimated)INMDInMode$181.27M$2.476.148.36N/A44.50%18.38%16.35%10/29/2025 (Estimated)IRMDiRadimed$19.23M$1.6244.2135.81N/A26.61%23.30%20.62%10/30/2025 (Estimated)OMOutset Medical-$127.98M-$20.29N/A∞N/A-82.06%-97.17%-32.84%11/5/2025 (Estimated)Latest OM, INMD, IRMD, and EMBC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/8/2025Q3 2025EMBCEmbecta$0.7720$1.12+$0.3480$0.78$278.15 million$295.50 million7/30/2025Q2 2025INMDInMode$0.50$0.47-$0.03$0.42$98.45 million$95.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEMBCEmbecta$0.603.94%N/A41.96%N/AINMDInModeN/AN/AN/AN/AN/AIRMDiRadimed$0.680.95%N/A41.98%1 YearsOMOutset MedicalN/AN/AN/AN/AN/ALatest OM, INMD, IRMD, and EMBC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/6/2025EMBCEmbectaquarterly$0.154.14%8/29/20258/29/20259/15/20257/31/2025IRMDiRadimedquarterly$0.171.13%8/18/20258/18/20258/28/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEMBCEmbectaN/A2.471.78INMDInModeN/A9.608.58IRMDiRadimedN/A8.787.51OMOutset Medical0.637.476.05Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEMBCEmbecta93.83%INMDInMode68.04%IRMDiRadimed92.34%OMOutset MedicalN/AInsider OwnershipCompanyInsider OwnershipEMBCEmbecta0.42%INMDInMode6.92%IRMDiRadimed36.80%OMOutset Medical2.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEMBCEmbecta2,10058.49 million58.24 millionOptionableINMDInMode48063.21 million58.84 millionOptionableIRMDiRadimed11012.72 million8.04 millionOptionableOMOutset Medical52017.77 million17.34 millionNot OptionableOM, INMD, IRMD, and EMBC HeadlinesRecent News About These CompaniesOutset Medical, Inc. (OM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript1 hour ago | seekingalpha.comHead-To-Head Comparison: Outset Medical (NASDAQ:OM) versus Aspyra (OTCMKTS:APYI)September 9 at 2:55 AM | americanbankingnews.com231,099 Shares in Outset Medical, Inc. $OM Purchased by Parkman Healthcare Partners LLCSeptember 8 at 7:45 AM | marketbeat.comAlyeska Investment Group L.P. Makes New $18.84 Million Investment in Outset Medical, Inc. $OMSeptember 7 at 5:23 AM | marketbeat.comOUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmSeptember 4, 2025 | globenewswire.comBirchview Capital LP Sells 344,182 Shares of Outset Medical, Inc. $OMSeptember 4, 2025 | marketbeat.comOutset Medical announces collaboration Northwest Kidney CentersSeptember 3, 2025 | msn.comNorthwest Kidney Centers Partners with Outset Medical to Enhance Home Hemodialysis Access with Tablo SystemSeptember 3, 2025 | quiverquant.comQNorthwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home HemodialysisSeptember 3, 2025 | globenewswire.comDurable Capital Partners LP Invests $19.25 Million in Outset Medical, Inc. $OMSeptember 3, 2025 | marketbeat.comGMT Capital Corp Cuts Stake in Outset Medical, Inc. $OMSeptember 1, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Makes New $17.73 Million Investment in Outset Medical, Inc. $OMAugust 27, 2025 | marketbeat.comOutset Medical (NASDAQ:OM) Given Sector Perform Rating at Royal Bank Of CanadaAugust 21, 2025 | marketbeat.comOutset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare ConferenceAugust 20, 2025 | globenewswire.comOutset Medical, Inc. $OM Shares Sold by National Bank of Canada FIAugust 19, 2025 | marketbeat.comOutset Medical’s Earnings Call Highlights Strong GrowthAugust 15, 2025 | theglobeandmail.comOutset Medical (OM) Receives a Hold from OppenheimerAugust 15, 2025 | theglobeandmail.comOutset Medical Inc.August 15, 2025 | barrons.comAfter Plunging 26.8% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical (OM)August 15, 2025 | zacks.comWhat To Expect From Outset Medical Inc (OM) Q2 2025 EarningsAugust 7, 2025 | finance.yahoo.comOutset Medical Reports Strong Q2 Growth and Raises GuidanceAugust 7, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 2025An Atomic Sized Surge Is Brewing for NuScale Power Stock PriceBy Thomas Hughes | August 11, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 2025Can AI Defense Contracts Push Palantir Shares Higher?By Chris Markoch | August 19, 2025Broadcom Named in Apple’s $100B U.S. Investment PlanBy Leo Miller | August 22, 2025OM, INMD, IRMD, and EMBC Company DescriptionsEmbecta NASDAQ:EMBC$14.92 -0.32 (-2.07%) As of 10:16 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.InMode NASDAQ:INMD$15.22 +0.15 (+1.00%) As of 10:17 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.iRadimed NASDAQ:IRMD$71.62 -0.27 (-0.37%) As of 10:16 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.Outset Medical NASDAQ:OM$13.72 -0.47 (-3.31%) As of 10:16 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle Has Spoken: AI Changes Everything Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Should You Buy Figma Stock After Its 55% Post-IPO Drop? Ulta Beauty Stock: Strong Growth, Short-Term Volatility Ahead Joby's Stock Is Quiet, But a Storm of Catalysts Is Brewing Beyond DIY: Home Depot's Conquest of the Professional Market The Quiet Before the Catalyst: Vertical Aerospace's Next Move Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
